Si informa che il 1° agosto 2017 è diventata efficace la fusione per incorporazione di Alfa Wassermann S.p.A., unitamente a Sigma-Tau Industrie Farmaceutiche Riunite S.p.A e Biofutura Pharma S.p.A. in Alfasigma S.p.A.

L’operazione dà vita ad un nuovo protagonista del mondo farmaceutico.

Si comunica, inoltre, che la presente pagina diventerà inattiva e non sarà più aggiornata. Invitiamo, pertanto tutti i nostri followers a seguire la nuova pagina LinkedIn di Alfasigma: 

https://lnkd.in/dNnmX89


Pharmaceutical

Sigma-tau

Dave Lemus

Bruffa Umberto

Giovanni Salvatori

Marinella Sanna

Manuel Gasparin

Roberta Cainero

Roberto Camerini

Ferdinando Maria Milazzo

Mauro Bove

The Research and Development team at Sigma-tau, which has now merged into Alfasigma S.p.A., focuses on innovative pharmaceutical research. This team comprises of experts such as Laboratory Specialists, Heads of Molecular Oncology and Clinical Research, Pharmaceutical Researchers, and specialists in Laboratory Method Development and Stability. Their work involves the development and testing of new medical treatments, molecular oncology advancements, and ensuring the stability and efficacy of pharmaceutical products through rigorous clinical and laboratory research.

Research and Development

Marketing

Research and Development

About

Team members

Other teams at Sigma-tau

Marketing